Registration for a live webinar on 'Innovative Vaccines and Viral Pathogenesis: Insights from Recent Monkeypox (Mpox) Research' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this free, full length talk
Topics Covered
- Overview of the saliva SARS-COV-2 test
- Benefits of this diagnostic test
- Test development and accuracy
- Manufacturing capabilities
Biography
Dr. Andy Brooks is the Chief Operating Officer and Director of Technology Development of RUCDR Infinite Biologics at Rutgers University. As the COO, Dr. Brooks oversees the operations of all laboratories within RUCDR, ensuring consistent and superior quality standards for all services. RUCDR Infinite Biologics is the world’s largest university-based biorepository with a focus on creating and implementing technologies for biomaterial quality control and sample chain of custody.
Dr. Brooks is a molecular neuroscientist, whose research focuses on deciphering the molecular mechanisms that underlie memory and learning. Dr. Brooks is a well-recognized genomicist and has been involved in the development and implementation of cutting edge molecular based technologies for both nucleic acid and protein analyses. He has worked to automate and develop the service infrastructure to provide high-throughput sample management and analysis for DNA, RNA, and protein-based technologies to hundreds of labs globally.
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Brooks, A. (2020, May 5). An FDA approved salivary test for SARS-CoV-2 infection [Audio file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved November 23, 2024, from https://doi.org/10.69645/LPNE6935.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Andrew Brooks has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Other Talks in the Playlist: Interviews on Covid-19
Transcript
Quiz
Disclaimer: This quiz is intended for learning assessment purposes only and does not grant any certification or credit.
If you are interested in getting a certificate for watching the talk, follow the instructions in this talk's Accreditation Information (where available.)